Nov 19, 2020 / 05:30PM GMT
Kyle William Rose - Canaccord Genuity Corp., Research Division - Senior Analyst
Good afternoon, and thank you for joining us at this year's Canaccord Genuity Medical Technology and Diagnostics Forum. My name is Kyle Rose. I'm on the MedTech team here at Canaccord Genuity. And joining us this afternoon is Insulet, who is a top player in the insulin pump market with its novel form factor and pay-as-you-go business model.
The company recently delivered strong Q3 results and with a new product cycle on the horizon, looks to be entering an exciting period of execution. So with us this afternoon are several members of management, including Wayde McMillan, CFO; Bret Christensen, CCO; as well as Deb Gordon, VP of Investor Relations.
Before we kick it off, the lawyers and my compliance team always request that I mention any relevant disclosures, if and where applicable, they can be found in our conferencing or firm website. So with that, I'll jump into some discussion. It's going to be back and forth Q&A with some fireside. So if the investors on the line want to submit questions to the
Insulet Corp at Canaccord Genuity Medical Technologies & Diagnostics Forum (Virtual) Transcript
Nov 19, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers